Thursday, February 27, 2025 | 04:42 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Glenmark Pharmaceuticals Share Price

Know More
BSENSE

₹1,313.00-3.30 (-0.25%)

04:01 PM, 27-Feb-2025

₹1,313.35-3.00 (-0.23%)

03:52 PM, 27-Feb-2025

BSE : 532296

NSE : GLENMARK

Sector : Health care

ISIN Code : INE935A01035

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 27-Feb-2025 | 10:31 AM IST

Market Cap (₹ Cr)

37,053

Traded Value (₹ Cr)

0.56

Volume (Shares)

4,296

Face Value (₹)

1

52-Week High (₹)

1,830.05

52-Week High Date

15-Oct-2024

52-Week Low (₹)

883.50

52-Week Low Date

14-Mar-2024

All Time High (₹)

1,830.05

All Time High Date

15-Oct-2024

All Time Low (₹)

1.89

All Time Low Date

10-Feb-2000

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd was incorporated in November 18th 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology Respiratory and Dermatology. Its branded generics business has a significant presence in markets across emerging economies including India. The company has 14 manufact...
Read More

Glenmark Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

37,063

EPS - TTM (₹) [C]

0.00

P/E Ratio (X) [C]

-

Face Value (₹) 1
Latest Dividend (%)250.00
Latest Dividend Date 13-Sep-2024
Dividend Yield (%) 0.19
Book Value Share (₹) [C]299.29
P/B Ratio (₹) [C]4.39

Funds Owning this Stock

Load more

Research Reports

DateBrokerActionPrices(₹) Report
27-Dec-2024Geojit Financial Services Accumulate 1,720
28-May-2024Edelweiss Securities Hold 1,200

Stock Strength

Today's Low/High (₹)

1,293.10

1,318.95

Week Low/High (₹)

1,281.35

1,386.00

Month Low/High (₹)

1,280.30

1,553.00

Year Low/High (₹)

883.00

1,831.00

All time Low/High (₹)

1.89

1,831.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-2.64%-2.64%-1.48%-1.61%
1 Month-6.32%-6.22%-1.00%-1.24%
3 Month-13.79%-13.74%-7.01%-7.13%
6 Month-23.05%-23.07%-8.69%-9.88%
1 Year41.59%41.58%2.08%1.56%
3 Year190.44%190.53%33.57%35.34%

Company Info

Company Information

Chairman & Managing Director : Glenn Saldanha

Executive Director (Corporate) : Cheryl Pinto

Executive Director & Group CFO : V S Mani

Non Executive Director : B E Saldanha

Independent Non Exe. Director : Rajesh Desai.

Independent Non Exe. Director : Sona Saira Ramasastry

Independent Non Exe. Director : Dipankar Bhattacharjee

Independent Non Exe. Director : V R Iyer

Additional Director : Pradeep Kumar Sinha

Registered Office: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road,Mumbai,Maharashtra-400026 Ph: 91-22-40189999

Email:complianceofficer@glenmarkpharma.com

URL:http://www.glenmarkpharma.com

FAQs about Glenmark Pharmaceuticals Ltd

1. What's the Glenmark Pharmaceuticals Ltd share price today?
Glenmark Pharmaceuticals Ltd share price was Rs 1,313.00 at 04:01 PM IST on 27th Feb 2025. Glenmark Pharmaceuticals Ltd share price was down by 0.25% from the previous closing price of Rs 1,316.30. Glenmark Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Glenmark Pharmaceuticals Ltd share price moved down by 6.32% on BSE
  • Last 3 Months: Glenmark Pharmaceuticals Ltd share price moved down by 13.79% on BSE
  • Last 12 Months: Glenmark Pharmaceuticals Ltd share price moved up by 41.59% on BSE
  • Last 3 Years: Glenmark Pharmaceuticals Ltd price moved up by 190.44% on BSE


2. How can I quickly analyse the performance of the Glenmark Pharmaceuticals Ltd stock?
The performance of the Glenmark Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is _
  • Price to book value ratio is 4.39
  • Dividend yield of 0.19
  • The EPS (trailing 12 months) of the Glenmark Pharmaceuticals Ltd stock is Rs 0.00


3. What is the market cap of Glenmark Pharmaceuticals Ltd?
Glenmark Pharmaceuticals Ltd has a market capitalisation of Rs 37,053 crore.


4. What is Glenmark Pharmaceuticals Ltd's 52-week high/low share price?
The Glenmark Pharmaceuticals Ltd’s 52-week high share price is Rs 1,830.05 and 52-week low share price is Rs 883.50.


5. Is the Glenmark Pharmaceuticals Ltd profitable?
On a consolidated basis, Glenmark Pharmaceuticals Ltd reported a profit of Rs 413.80 crore on a total income of Rs 2,380.47 crore for the quarter ended 2024. For the year ended Dec 2024, Glenmark Pharmaceuticals Ltd had posted a profit of Rs 348.03 crore on a total income of Rs 3,418.68 crore.


6. Which are Glenmark Pharmaceuticals Ltd’s peers in the Health care sector?
Glenmark Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Alkem Lab, Glaxosmi. Pharma, Biocon, Glenmark Pharma., Ipca Labs., Ajanta Pharma, Suven Pharma.


7. Who owns how much in Glenmark Pharmaceuticals Ltd?
Key changes to the Glenmark Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Glenmark Pharmaceuticals Ltd has gone up to 46.65 per cent as of Dec 2024 from 46.64 per cent as of Mar 2024.
  • Foreign Institutional Investors holding in Glenmark Pharmaceuticals Ltd has gone up to 23.51 per cent as of Dec 2024 from 21.38 per cent as of Mar 2024.
  • Indian Public holding in Glenmark Pharmaceuticals Ltd has gone down to 12.65 per cent as of Dec 2024 from 14.83 per cent as of Mar 2024.
  • Mutual Funds Uti holding in Glenmark Pharmaceuticals Ltd has gone up to 12.12 per cent as of Dec 2024 from 10.55 per cent as of Mar 2024.
  • Non Institutional Investors holding in Glenmark Pharmaceuticals Ltd has gone down to 3.31 per cent as of Dec 2024 from 3.75 per cent as of Mar 2024.
  • Other Institutional Investors holding in Glenmark Pharmaceuticals Ltd has gone up to 1.29 per cent as of Dec 2024 from 0.46 per cent as of Mar 2024.
  • Insurance Companies holding in Glenmark Pharmaceuticals Ltd has gone down to 0.47 per cent as of Dec 2024 from 2.25 per cent as of Mar 2024.
  • Financial Institutions holding in Glenmark Pharmaceuticals Ltd has gone down to 0.00 per cent as of Dec 2024 from 0.14 per cent as of Mar 2024.
  • Custodians holding in Glenmark Pharmaceuticals Ltd has gone up to 0.00 per cent as of Dec 2024 from 0.00 per cent as of Mar 2024.